학술논문
Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs)
Document Type
Article
Author
Source
In European Journal of Medicinal Chemistry July 2013 65:477-486
Subject
Language
ISSN
0223-5234